Rhumbline Advisers Aura Biosciences, Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 64,038 shares of AURA stock, worth $343,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,038
Previous 73,619
13.01%
Holding current value
$343,243
Previous $605,000
32.89%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AURA
# of Institutions
96Shares Held
39.8MCall Options Held
1.9KPut Options Held
31K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$37.1 Million2.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$26.2 Million0.07% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.08MShares$21.9 Million0.64% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$16.3 Million4.98% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$16.1 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $157M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...